Approval · Notice of Compliance 3758 · 1997
LOVENOX: Notice of Compliance 3758
Issued November 26, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3758
- Date
- November 26, 1997
- Company
- Rhone-Poulenc Rorer Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for new presentation: 40mg/0.4ml prefilled syringes and additional indications: prophylaxis of thromboembolic disorders in patients undergoing high risk abdominal, gynecological or urological surgeries; colorectal surgery
- Therapeutic class
- Antithrombotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOVENOX | 02236883 | Marketed |
Medicinal ingredients
- ENOXAPARIN SODIUM 40 MG per SYR